Input: Could not generate response.

Response:
pedophilia and,  223–225

premature ejaculation and, 117–120

sexual interest arousal disorder (SIAD),  21–26

vaginismus,  179–181, 180f

Evolutionary factors, 313–314

Examination, physical. See Physical examination

Exercise,  421

Ex-gay therapy, 312–313

Exhibitionism, 197,  198,  406–407\.  See also Paraphilias Experiential approach, 472–474

Experiential Psychotherapy. See also Treatment

case example of, 207–214

overview, 196,  213–214

paraphilias and,  204–207

Exposure therapy, 183–184, 185–186,  187–190

**F**

Family factors, 316

Family therapy, 244–245

Family-of-origin factors, 47–48

Fear, 141,  384–385

Fear-avoidance model of chronic pain, 177\.  See also Fear-avoidance model of vaginismus (FAM-V); Vaginismus Fear-avoidance model of vaginismus (FAM-V), 180–181, 180f,  189–190\.  See also Fear-avoidance model of chronic pain; Vaginismus

Female orgasmic disorder (FOD). See also Orgasm disorders in women

adolescents and young adults,  515

assessment and diagnostic issues,  93–98

case example of, 102–106

epidemiology, 91–93

etiology, 98–99

overview, 90–91,  106–107

treatment and,  99–102, 103f

Female sexual arousal disorder (FSAD)

diagnosis and classification of,  97

disability and,  469–470

persistent genital arousal disorder (PGAD),  268

replacement of in the DSM-5, 2–3,  17

Female Sexual Distress Scale (FSDS), 446,  516

Female Sexual Function Index (FSFI), 49,  268, 382,  425,  446, 463

Female Sexual Function Questionnaire, 344–345

Female Sexual Functioning Inventory, 516

Female sexual interest/arousal disorder (FSIAD),  425–426

Fetishism,  197, 198\.  See also Paraphilias Follicle-stimulating hormone (FSH), 29

Fragmentation of sex therapy, 549–551

Frotteurism, 197,  198\.  See also Paraphilias 511

**G**

Gay sexuality. See also LGBTQ clients

aging and, 528

case example of, 324–325

clinical issues,  323–325

emerging trends,  319

therapeutic challenges for, 6–7

Gender

aging and, 526–527

body image and,  362,  364–365

DSM-5 and,  3–4

gender identity,  73

infertility and,  421–422

infidelity and,  404

masturbation and,  94

Gender dysphoria

adolescents,  246–249

adults,  249–258

assessment and,  240–241

case example of, 248–249,  253–255

children,  244–246

diagnosis and,  238–240

epidemiology, 236–238

etiology, 241–243

female-to-male transsexuals,  252

male-to-female transsexuals,  250–252

overview, 5,  235–236, 258

phenomenology,  236

prevalence, 236–238

treatment and,  244–258

Gender identity disorder (GID),  236, 238–240,  316–317\.  See also Gender dysphoria Gender Identity/Gender Dysphoria Questionnaire for Adolescents and Adults,  241

Gender reassignment. See Gender dysphoria; Sex reassignment surgery (SRS)

Gender-variant youth, 325–327. See also Transgender clients Generalized anxiety disorder,  72–73\.  See also Anxiety Genetic factors

adolescents and young adults,  517

delayed ejaculation and, 140–141

LGBTQ clients,  311

orgasm disorders in women and,  98

premature ejaculation and,  118

Genital body image, 361–364\.  See also Body image Genital herpes. See Herpes

Genital pain. See also Dyspareunia; Vaginismus; Vulvodynia; Provoked vestibulodynia adolescents and young adults,  515

assessment and diagnosis of,  161–163

case example of, 170–173

etiology, 163–164

male dyspareunia,  164–165

multidisciplinary model of care, 169–170

overview, 159–161,  173

treatment and,  165–170

Genital sensation,  20–21,  34–35, 463–464

Genital shrinking syndromes, 338–339

Genital vasodilation, 267

Genitopelvic pain/penetration disorder,  3, 161\.  See also Dyspareunia; Genital pain Global Study of Sexual Attitudes and Behaviors (GSSAB), 337,  353–354

512

Gold-star pedophiles, 222–223. See also Pedophilia Golombok–Rust Inventory of Sexual Satisfaction (GRISS)

adolescents and young adults,  516

chronic illness and,  446

hypoactive sexual desire disorder (HSDD) in men and, 49

infertility and,  425

Gonorrhea,  496. See also Sexually transmitted infections (STIs) Group cognitive-behavioral sex therapy, 167–168, 170–173,  427. See also Cognitive-behavioral therapy (CBT) Group therapy,  287f, 291–293\.  See also Group cognitive-behavioral sex therapy Guided masturbation. See Directed masturbation

Guilt, 25–26,  201–202,  290t

Gynecological conditions, 99\.  See also Medical problems

**H**

Harm reduction approaches, 324–325

Harry Benjamin Society Standards of Care (SOC), 316–317

Head injury, 224

Hebephilia. See also Pedophilia

diagnosis and,  229

overview, 222

Prevention Project Dunkelfeld,  225–226

referral issues,  230

Hepatitis,  499. See also Sexually transmitted infections (STIs) Heritability,  98

Herpes. See also Sexually transmitted infections (STIs)

affected individuals and couples,  492–493

impact of, 501–502

overview, 496–497

Heterosexuality, 319–320

Hidden sexual desire disorder, 43,  49–50,  53

High blood pressure,  421

HIV. See also Sexually transmitted infections (STIs)

case example of, 324–325

gay male sexuality and, 323–325

impact of, 501–502

overview, 498–499

prevalence, 488–490,  489f

testing for, 487

therapeutic challenges for, 8

Homosexuality,  311–313,  528. See also Gay sexuality; Lesbian sexuality; LGBTQ clients; Sexual orientation Honesty in therapy,  122–123

Hormonal treatment. See also Pharmacological treatment; Treatment

gender dysphoria and, 246–247, 249

gender-variant youth and,  326–327

overview, 237–238

sexual interest arousal disorder (SIAD) and,  32–33

Hormones

delayed ejaculation and, 142–143

gender dysphoria and, 241

hypoactive sexual desire disorder (HSDD) in men,  47

sexual interest arousal disorder (SIAD),  22–24,  32–33

HPV. See also Sexually transmitted infections (STIs)

affected individuals and couples,  492–493

case example of, 493–495

impact of, 501

overview, 497–498

513

Human immunodeficiency virus (HIV). See HIV

Human papillomavirus (HPV). See HPV

Hyperalgesic genital area, 543

Hyperandrogenic states in women, 23

Hyperprolactinemia (HPRL),  47

Hypersexual Behavior Inventory,  284

Hypersexual disorders (HDs)

assessment and diagnostic issues,  286–289,  287f

case example of, 291–293,  294–295,  298–299

overview, 280–286,  283t,  299–300

treatment and,  289–299,  290t

Hypersexuality,  5, 265\.  See also Sexual compulsivity/addiction Hyperthyroidism, 118

Hypervigilance, 182–183, 266–267

Hypnotherapy,  168. See also Treatment

Hypoactive sexual desire disorder (HSDD) in men. See also Low desire; Male sexual desire assessment and diagnostic issues,  49–50

case example of, 55–58

comorbidities and, 45–46

defining problems,  43–44

in the DSM-5,  3

epidemiology, 44–45

etiology and models,  46–49

hypersexual disorders (HDs) and,  288

overview, 42–44,  58

treatment and,  45, 50–54,  54f

Hypoactive sexual desire disorder (HSDD) in women. See also Low desire; Sexual interest arousal disorder (SIAD) culturally sensitive sex therapy (CSST) and,  336

hypersexual disorders (HDs) and,  288

replacement of in the DSM-5, 2–3,  17

Hypogonadism,  527

Hypothalamic–pituitary–gonadal axis, 66

Hypothalamus, 24

Hypothyroidism,  51

**I**

Illegal behavior, 198–199\.  See also Paraphilias; Sex offenders Illness, 7–8,  99. See also Medical problems In vivo exposure therapy, 185–186, 187–190\.  See also Exposure therapy Incentive motivation model of sexual response,  21–22,  26

Individual therapy,  287f

Infertility. See also Medical problems

assessment and diagnostic issues,  422–426,  424f

case example of, 429–432

early intervention and,  432–433

epidemiology, 420–422

overview, 419–420,  433

sexually transmitted infections (STIs) and,  495–496

therapeutic challenges for, 8

treatment and,  421, 426–429,  432–433

Infidelity. See also Relational aspects

assessment and,  408

case example of, 55–56,  400–403,  408–410

as the cause of sexual dysfunction, 412

contexts of,  406–407

monogamy and,  403–404

514

motivations for, 411–412

overview, 399–400,  413

prevalence, 404

research on, 404–406

sexually transmitted infections (STIs) and,  491–492, 504

therapeutic challenges for, 7

treatment and,  405–408

Inhibition, 95–96

Institute for Personal Growth (IPG), 320

Integrated approach, 77–80, 152f,  388,  405–406

Integrated biological model, 140–141

Interdisciplinarity, 545–546,  551, 553

International Academy of Sex Research (IASR),  551

International Classification of Diseases (ICD), 5,  6,  43–44

International Index of Erectile Function (IIEF)

adolescents and young adults,  516

chronic illness and,  446

culturally sensitive sex therapy (CSST) and,  345

erectile dysfunction and, 77

hypoactive sexual desire disorder (HSDD) in men,  49

infertility and,  425

overview, 66

International Society for Sexual Medicine (ISSM),  114

International Society for the Study of Vulvovaginal Disease (ISSVD),  160–161

International Society for the Study of Women's Sexual Health (ISSWSH), 551

International Society of Sexual Medicine, 101–102

Internet,  226–227,  290t

Interpersonal factors, 164

Interpersonal issues,  74. See also Relational aspects

Intersystems approach,  405

Interventions. See Treatment

Interview, structured. See Structured interview

Intimacy,  289, 427\.  See also Relational aspects Intravaginal ejaculatory latency time (IELT), 140,  142,  337–338\.  See also Delayed ejaculation **K**

Kegel exercises, 99

Kinsey Institute's rating scales, 283

**L**

Labiaplasty, 363–364

Laboratory investigation, 26,  29, 49–50,  66. See also Assessment Late-life sexuality. See Aging

Lesbian sexuality. See also LGBTQ clients

aging and, 528

case example of, 321–323

clinical issues,  320–323

emerging trends,  319

therapeutic challenges for, 6–7

LGBTQ clients. See also Bisexuality; Gay sexuality; Lesbian sexuality; Queer individuals; Sexual minorities; Sexual orientation; Transgender clients

aging and, 528

case example of, 321–323,  324–325,  328–329

clinical issues,  319–329

515

culture of disability,  459

DSM-5 and,  316–317

emerging trends,  317–319

gender-variant youth,  325–327

overview, 309–310,  329

pathology model, 311–313

queer theory paradigm and,  313–316

therapeutic challenges for, 6–7

Lifelong vaginismus. See Vaginismus

Lifespan view of sexuality. See also Developmental view of sexuality

body image and,  365

erectile dysfunction and, 62–63

gender dysphoria,  237–238

hypoactive sexual desire disorder (HSDD) in men,  46

orgasm disorders in women,  92–93

premature ejaculation and, 117

therapeutic challenges for, 8–9

Long-term-care settings,  528–529\.  See also Aging Low desire,  3. See also Desire; Hypoactive sexual desire disorder (HSDD) in men; Hypoactive sexual desire disorder (HSDD) in women; Male sexual desire; Sexual interest arousal disorder (SIAD)

**M**

Major depressive disorder (MDD),  25. See also Depression

Male sexual desire. See also Desire; Hypoactive sexual desire disorder (HSDD) in men assessment and diagnostic issues,  49–50

comorbidities and, 45–46

defining problems,  43–44

epidemiology, 44–45

etiology and models,  46–49

overview, 42–44,  58

treatment and,  45

Male Sexual Health Questionnaire (MSHQ), 144–145

Marriage,  24–25,  336\.  See also Relational aspects Masters and Johnson's linear sexual response cycle, 18,  37–38

Masturbation. See also Directed masturbation

culturally sensitive sex therapy (CSST) and,  343–344

delayed ejaculation and, 141–142,  144, 145

infidelity and,  406–407

orgasm disorders in women and,  94

people with disabilities and,  473–474

persistent genital arousal disorder (PGAD) and,  264,  269–270,  271

premature ejaculation and,  115,  127

sexual interest arousal disorder (SIAD) and,  31

sociocultural factors and,  25–26

Masturbation retraining, 145\.  See also Masturbation; Treatment McCoy Female Sexuality Questionnaire, 344

Medical assessment. See Physical examination

Medical problems. See also Chronic illness; Disability; Infertility; Physical examination adolescents and young adults,  514–515

aging and, 526,  528, 531–532

delayed ejaculation and, 139,  140–141, 142–143, 152f

erectile dysfunction and, 65–69

gender dysphoria and, 238

genital pain and,  160–161, 163

hypersexual disorders (HDs) and,  288

hypoactive sexual desire disorder (HSDD) in men,  47,  49–50,  51

516

infertility and,  421

orgasm disorders in women and,  99

persistent genital arousal disorder (PGAD),  267–268

sexual interest arousal disorder (SIAD),  22–24

therapeutic challenges for, 7–8

vaginismus and, 179

Medical professionals, 9–10

Medical sexology, 453

Medical treatment. See also Pharmacological treatment

delayed ejaculation and, 152f

erectile dysfunction and, 69–71

genital pain, 159,  166–167

hypoactive sexual desire disorder (HSDD) in men,  54f

infertility and,  427–428

orgasm disorders in women and,  101

people with disabilities and,  467

persistent genital arousal disorder (PGAD) and,  273

premature ejaculation,  113

vaginismus and, 184

Medications. See Pharmacological treatment

Medroxyprogesterone, 296–297

Melanocortin system,  22

Menopausal status, 99,  526. See also Aging Mental health providers,  9–10

Metatheoretical approaches, 467–468

Mindfulness skills, 27f,  271, 470\.  See also Treatment Mindfulness-based cognitive therapy,  27f, 35–37. See also Treatment Mindfulness-based cognitive-behavioral therapy, 270–271\.  See also Treatment Mindfulness-based stress reduction (MBSR), 32. See also Treatment Mindfulness-based techniques, 31–32,  100, 385–386\.  See also Treatment Minnesota Multiphasic Personality Inventory (MMPI), 77

Minnesota Multiphasic Personality Inventory-2 (MMPI-2),  241

Monogamish relationships, 323–324. See also Relational aspects Monogamy, 403–404, 486–487,  490, 503\.  See also Relational aspects Mood,  25

Mood disorders,  287–288,  442

Mood stabilizers, 296–297

Motivation, treatment, 182

Motivational interviewing techniques, 49–50

Multidimensionality,  544–545, 545–546

Multidisciplinary models

case example of, 170–173

dyspareunia and,  169–170

hypoactive sexual desire disorder (HSDD) in men and, 49–50

overview, 4

Multifactorial model, 243

Multiple sclerosis,  142–143

**N**

National Institute on Disability and Rehabilitation Research (NIDRR), 458

National Longitudinal Study of Adolescent Health, 513

National Survey of Sexual Attitudes and Lifestyles (NATSAL), 20,  92

National Vulvodynia Association, 169

Negative thoughts, 368\.  See also Cognitive distortions

Nerve conduction abnormalities,  118

Neurological conditions,  99, 224\.  See also Medical problems 517

Neuropathy,  266

Neurosteroids,  23

Neurotransmitters, 22–24

Noncturnal penile tumescence and rigidity (NPTR) testing,  66

Nongenital sensation, 20–21

Nonmonogamous relationships, 323–324, 327–329. See also Polyamory; Relational aspects Nonparaphilic hypersexuality disorders. See Hypersexual disorders (HDs)

Norepinephrine system, 22

Nutrition, 421

Nutritional supplements, 101

**O**

Obsessive–compulsive disorder,  72–73,  229–230

Olfactory aversion, 296

Opiate antagonists,  296–297

Oral contraceptives, 23,  514–515

Oral erectogenic agents, 535

Orgasm. See also Delayed ejaculation; Ejaculation; Premature ejaculation (PE)

adolescents and young adults,  513–514

overview, 4,  90,  543

persistent genital arousal disorder (PGAD) and,  269–270, 271

Orgasm disorders in women. See also Female orgasmic disorder (FOD)

adolescents and young adults,  515

assessment and diagnostic issues,  93–98

case example of, 102–106

epidemiology, 91–93

etiology, 98–99

overview, 89–91,  106–107

treatment and,  99–102, 103f

Orgasmic reconditioning,  429

Overactive bladder (OAB), 267

Oxytocin system, 22

**P**

Pain, genital. See Genital pain

Pain management, 159,  166–168

Pair bond, 289\.  See also Relational aspects

Paraphilia not otherwise specified (NOS), 197\.  See also Paraphilias Paraphilia-related disorder (PRD), 282

Paraphilias. See also Pedophilia

assessment and,  201–202

case example of, 207–214

compared to hypersexual disorders,  281

erectile dysfunction and, 73

Experiential Psychotherapy and,  204–207,  213–214

infidelity and,  406–407

origins of desire(s), 200

overview, 5–6,  195–200,  213–214

treatment and,  202–207,  213–214

Parent counseling, 244–245

Parenting,  242–243

Passive attitude towards sexuality,  25–26

Pathology model, 311–313,  312

PDE5 inhibitors, 131–132\.  See also Pharmacological treatment 518

Pedophilia. See also Paraphilias

case example of, 220–222,  230–231

confidentiality in treatment and, 227–229

diagnosis and,  229–230

duty to warn and, 227–229

etiology, 223–225

infidelity and,  406–407

interventions,  226–227

overview, 197,  198,  219–223,  230–231

Prevention Project Dunkelfeld,  225–226

referral issues,  230

Peer group therapy, gender dysphoria and,  244–245

Pelvic floor muscle (PFM) dysfunction,  163, 179,  183

Pelvic floor physical therapy,  167, 184,  273–274. See also Treatment Pelvic inflammatory disease (PID),  421, 495–496

Pelvic reactivity,  183

Pelvic-region surgery, 142–143. See also Medical problems Penetration phobia. See Vaginal penetration phobia

Penile sensitivity,  118, 142–143\.  See also Medical problems Penis size,  362–363\.  See also Body image People with disabilities (PWD). See also Disability

assessment and diagnostic issues,  461–466

case example of, 471,  474–477

overview, 458,  477

treatment and,  466–474

Performance anxiety,  72, 120,  468–469. See also Anxiety Permission-limited information-specific suggestions-intensive therapy (PLISSIT) model,  485, 491–492

Persistent genital arousal disorder (PGAD)

assessment and diagnostic issues,  268–270, 269f

case example of, 274–277

medical conditions associated with,  267–268

overview, 5,  263–267, 277

pelvic floor physical therapy and, 273–274

sexual dysfunctions in,  268

symptomatology, 265–266

treatment and,  270–273

Persistent sexual arousal syndrome, 263, 264. See also Persistent genital arousal disorder Pharmaceutical industry,  2–3

Pharmacological treatment. See also Medical treatment; Treatment

adolescents and young adults,  514–515,  518–520

aging and, 530–531

chronic illness and,  442

defensiveness and fragmentation in the field of sex therapy,  550

delayed ejaculation and, 139,  142–143, 146–147

erectile dysfunction and, 62,  66–67, 69–71,  81

genital pain and,  166–167

hypersexual disorders (HDs), 287f, 288,  290t,  296–299

hypoactive sexual desire disorder (HSDD) in men,  47,  51, 54f

infertility and,  421

orgasm disorders in women and,  101

overview, 545–546

paraphilias and,  202

pedophilia and,  227

persistent genital arousal disorder (PGAD),  267, 268,  273

premature ejaculation and, 126,  131–134

sexual interest arousal disorder (SIAD),  27f, 32–35

treatment outcome and, 547–548

Physical abuse,  163–164

519

Physical examination. See also Assessment; Medical problems

chronic illness and,  445–446,  449–450

delayed ejaculation and, 140–141

erectile dysfunction and, 65–69

genital pain and,  162–163

hypersexual disorders (HDs) and,  287f

persistent genital arousal disorder (PGAD),  269–270, 269f

sexual interest arousal disorder (SIAD),  26, 28–29

sexually transmitted infections (STIs) and,  487

vaginismus and, 181

Physiological factors,  99, 463–464. See also Medical problems Plastic surgery, 363–364

Polemic debates in the field of sex therapy,  551–552

Political debates in the field of sex therapy, 551–552

Polyamory. See also Queer individuals; Relational aspects

case example of, 328–329

clinical issues,  327–329

emerging trends,  318–319

overview, 318n

Polythetic criteria, 19–20\.  See also Symptoms/criteria Pornography

case example of, 298–299,  493–495

hypersexual disorders (HDs), 290t, 297

infidelity and,  406–407

Postorgasmic illness syndrome (POIS), 139

Posttransition specifier, 240

Posttraumatic stress disorder, 72–73

Practical approach, 472–474

Pregnancy, 141,  337

Premature Ejaculation Diagnostic Tool, 516

Premature ejaculation (PE). See also Diminished ejaculatory disorders (DEDs)

adolescents and young adults,  513–514,  515

case example of, 114–115,  128–130

defining problems,  113–116

in the DSM-5,  4

etiology, 117–120

evaluation and assessment, 121–123, 124f

impact on the man and the couple,  120–121

orgasm disorders in women and,  94

overview, 112–113,  134, 543

prevalence, 117

sexual dysfunctions in a global context and,  337–338

treatment and,  124f, 125–134,  546

Premature orgasm in women, 4

Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking (PRESIDE), 20

Prevention interventions, 225–226, 488–490, 489f, 503

Progesterone receptors, 23–24

Progestins, 24

Progressive relaxation, 428–429

Prolactin (PRL), 47

Promiscuity, 281,  383\.  See also Hypersexual disorders (HDs) Prostate cancer,  56–58

Prostate-specific antigen (PSA),  47

Prostatitis, 118, 421

Prostitute dependence, 406–407

Provoked vestibulodynia (PVD), 161\.  See also Genital pain PSCB (psychosocial, cultural, and behavioral) model,  140–141,  143, 143–145,  144f,  145f

520

Psychodynamic therapy,  244–245,  289,  291

Psychoeducation. See also Treatment

aging and, 533–534

chronic illness and,  447–448

delayed ejaculation and, 146

erectile dysfunction and, 78

gender dysphoria and, 255

hypersexual disorders (HDs), 290t

hypoactive sexual desire disorder (HSDD) in men,  50–51

infertility and,  433

orgasm disorders in women and,  99, 102, 103f

premature ejaculation and, 128

sexual interest arousal disorder (SIAD) and,  27f

Psychological factors

adolescents and young adults,  518–520

aging and, 531

chronic illness and,  440–442

delayed ejaculation and, 141–142

erectile dysfunction and, 63,  70–71, 72–73

hypoactive sexual desire disorder (HSDD) in men,  47–48

infertility and,  421

people with disabilities,  464

premature ejaculation and, 119–120

queer theory paradigm and,  313–314

vaginismus and, 179–180

Psychological model, 266–267

Psychological treatment,  184–185,  518–520. See also Treatment Psychological well-being, 440–442,  547

Psychometric instruments, 77,  94

Psychopathology, 198–199,  247–248

Psychosocial assessment and treatment

erectile dysfunction and, 71–81

gender dysphoria and, 244–245

infertility and,  422–426, 424f,  426–429

people with disabilities and,  468–469

persistent genital arousal disorder (PGAD),  269–270, 269f

Psychosocial factors

delayed ejaculation and, 140–141,  143–145,  144f, 145f

gender dysphoria and, 242–243

genital pain and,  161–162

orgasm disorders in women and,  98–99

Psychostimulants, 296–297

Psychotherapy, 113,  125–131, 133–134

Puberty, 246–247,  326–327

Public health care model,  249

Pudendal nerve,  266

**Q**

Quality of life, 62–63,  120–121

Queer individuals, 7\.  See also Bondage, dominance, sadism, masochism (BDSM); LGBTQ clients; Sexual minorities Queer theory paradigm, 313–316

Questionnaires, 49\.  See also Assessment

**R**

521

Rape, 198,  380n.  See also Paraphilias; Sexual abuse Rapid ejaculation, 323,  513–514. See also Premature ejaculation (PE) Rapid Risk Assessment of Sexual Offense, 229

Reassignment surgery. See Gender dysphoria; Sex reassignment surgery (SRS)

Recovering Couples Anonymous, 294

Referrals, 230,  237,  290t

Relapse prevention model, 203,  223,  295–296

Relational aspects. See also Infidelity; Marriage

chronic illness and,  442–444

delayed ejaculation and, 139–140,  141–142,  152f

disability and,  465, 473–474

erectile dysfunction and, 62–63,  73–76

gay male sexuality and, 323–324

gender dysphoria and, 256–257

genital pain and,  164

hypersexual disorders (HDs) and,  287f, 288,  289,  300

hypoactive sexual desire disorder (HSDD) in men,  48

infertility and,  421

lesbian sexuality and,  320–321

persistent genital arousal disorder (PGAD) and,  272–273

premature ejaculation and, 120–121

sexual interest arousal disorder (SIAD),  24–25

sexually transmitted infections (STIs) and,  486–487, 490–493,  500–503

Relationship skills-building interventions, 53,  548

Relaxation training

infertility and,  428–429

people with disabilities and,  468–469

sexual abuse and,  385

Religiosity

culturally sensitive sex therapy (CSST) and,  341

delayed ejaculation and, 141

infertility and,  428

LGBTQ clients,  312–313

masturbation and,  94

premature ejaculation and, 122

sexual interest arousal disorder (SIAD),  25–26

Renal failure, 47

Reparative therapy,  312–313

Resistance, 121–122,  128

Response, 268,  526,  542–544

Responsive desire, 22, 22–24,  422\.  See also Desire Restless genital syndrome (RGS),  267. See also Persistent genital arousal disorder (PGAD) Restless leg syndrome (RLS), 267

Revalidation of sexuality,  447

Risk factors. See also Etiology

body image and,  364–365

erectile dysfunction and, 66

pedophilia and,  224

sexually transmitted infections (STIs) and,  503

**S**

Safer sex. See also Sexually transmitted infections (STIs)

condoms and, 486

discussing with clients,  490, 504

HIV and,  502

Same-sex marriage, 336\.  See also Marriage

522

Satisfaction, sexual

aging and, 528

chronic illness and,  438

infertility and,  422

sexual abuse and,  379–380

treatment outcome and, 547

Schema-focused therapy,  388

Selective tissue estrogenic activity regulator (STEAR), 33–34

Selective-serotonin reuptake inhibitors (SSRIs). See also Pharmacological treatment adolescents and young adults,  514–515

aging and, 530–531

hypoactive sexual desire disorder (HSDD) in men,  47,  51

orgasm disorders in women and,  99, 101,  102, 103f

persistent genital arousal disorder (PGAD),  267, 273

premature ejaculation and, 132

Self-confidence,  120–121

Self-esteem. See also Body image

chronic illness and,  441–442

disability and,  464

erectile dysfunction and, 62–63

sexual interest arousal disorder (SIAD),  25

Self-factors, 72–73

Self-help books

dyspareunia and,  169

erectile dysfunction and, 78

hypersexual disorders (HDs), 294

premature ejaculation and, 128

Self-image. See Body image

Self-schemas,  387–388

Self-stimulation. See Masturbation

Sensate focus. See also Treatment

body image and,  369

chronic illness and,  449

erectile dysfunction and, 77

infertility and,  429

orgasm disorders in women and,  99, 100,  101–102, 103f

people with disabilities and,  468–469

sexual interest arousal disorder (SIAD) and,  31

Sensory awareness,  120


Input: Write a comprehensive document that covers a wide range of sexual disorders, including their symptoms, causes, and treatment options. Also, discuss the impact of sociocultural factors on these disorders and the role of sex therapy in addressing them. Please include information on paraphilias, sexual abuse, and sexually transmitted infections. Additionally, provide details on youth sexuality, including assessment, etiology, and treatment for young adults.

Response:
Serosorting approach,  324, 324–325

Serotonin receptors, 118

Serotonin–norepinephrine reuptake inhibitors (SNRIs), 267,  273\.  See also Pharmacological treatment Serum prostate-specific antigen (PSA) test, 66

Sex and Love Addicts Anonymous (SLAA), 294\.  See also 12-step programs Sex differences, 237

Sex education, 99,  102, 103f. See also Psychoeducation Sex Offender Risk Appraisal Guide,  229

Sex offenders. See also Paraphilias; Pedophilia

assessment and,  201–202

overview, 198–199

referral issues,  230

treatment and,  203–204,  214

Sex reassignment surgery (SRS). See also Gender dysphoria

attraction and, 239–240

male-to-female transsexuals,  250–252

overview, 237–238,  249–250

regretters,  257–258

relationship factors and, 256–257

523

Sex therapy in general. See also Culturally sensitive sex therapy (CSST) access to and cost of treatment,  553

aging and, 535–536

construct utility,  542–544

contribution of,  549

debates in,  551–552

defensiveness and fragmentation in the field of,  549–551

expectations from, 552–553

future of,  9–10

overview, 2–6,  541–542,  549,  553–554

therapeutic challenges for, 6–9

Sex toys, 472–473.  See also Masturbation

Sexaholics Anonymous, 294\.  See also 12-step programs

Sex-hormone-binding globulin (SHBG), 23

Sexual abuse. See also Child molestation; Pedophilia; Sex offenders

assessment and,  380–382

case example of, 389–395

epidemiology, 377–380

erectile dysfunction and, 73

genital pain and,  163–164

hypoactive sexual desire disorder (HSDD) in men,  47–48

overview, 375–377,  395

theoretical models,  383–385

treatment and,  385–389

Sexual addiction, 293–295

Sexual Addiction Screening Test, 283

Sexual attraction. See Attraction

Sexual aversion disorder, 2,  288

Sexual behavior,  383

Sexual Compulsives Anonymous, 294\.  See also 12-step programs Sexual Compulsivity Scale, 283

Sexual compulsivity/addiction,  5, 281\.  See also Hypersexual disorders (HDs); Hypersexuality Sexual deviance,  198–199\.  See also Deviance model; Paraphilias Sexual disorders,  5–6\.  See also individual disorders Sexual dysfunction. See also individual disorders

aging and, 529–532

culturally sensitive sex therapy (CSST) and,  341–343

in a global context,  336–339

overview, 2–4

persistent genital arousal disorder (PGAD),  268

sexual abuse and,  377–380

vaginismus and, 179–180

Sexual enhancement products ("sex toys"),  472–473\.  See also Masturbation; Sex toys Sexual functioning, 272–273, 360–365,  542–544\.  See also Sexual dysfunction Sexual interest arousal disorder (SIAD)

adolescents and young adults,  515

assessment and diagnostic issues,  26–29,  27f

case example of, 35–37

in the DSM-5,  2–3,  17

DSM-5 criteria for, 19–20

epidemiology, 20–21

etiology and models,  21–26

overview, 17,  37–38

treatment, 27f,  29–35

Sexual interests, unusual. See Paraphilias

Sexual masochism,  197. See also Paraphilias

Sexual medicine movement,  4, 6,  549–551

Sexual minorities,  6–7,  315–316. See also LGBTQ clients; Queer individuals 524

Sexual orientation. See also LGBTQ clients

erectile dysfunction and, 73

gender dysphoria and, 239–240,  244–245

queer theory paradigm and,  313–316

Sexual sadism, 197\.  See also Paraphilias

Sexual scripting approach, 79–80

Sexual Self-Consciousness Scale (SSCS), 446

Sexual stimulation techniques, 78–80

Sexual Tipping Point (STP) model, 143–145,  144f, 145f

Sexuality, 5,  383, 444

Sexually transmitted infections (STIs). See also HIV

affected individuals and couples,  490–493

aging and, 529

case example of, 483–485,  488, 490–491, 492,  493–495, 504–505

common STIs, 495–500

condoms,  486,  487–488

impact of, 500–503

infertility and,  422

overview, 482–488,  503–504

prevalence, 485–486,  488–490, 489f,  495–500,  529

professional, ethical, and legal regulations regarding,  503

sexual dysfunctions in a global context and,  337

testing for, 487–488

therapeutic challenges for, 8

Shame

gender dysphoria and, 254

hypersexual disorders (HDs), 290t

hypoactive sexual desire disorder (HSDD) in men,  47–48

paraphilias and,  201–202

sexually transmitted infections (STIs) and,  500–503

Shrinking genitals, 338–339

Social anxiety disorder, 288

Social factors,  312

Social support,  226–227,  312\.  See also Relational aspects Socialization, 48–49, 242–243

Society for Sex Therapy and Research (SSTAR), 551

Society for Sexual Medicine (SSM), 551

Society for the Scientific Study of Sex (SSSS),  551

Sociocultural factors. See also Cultural factors

disability and,  465

hypoactive sexual desire disorder (HSDD) in men,  48–49

premature ejaculation and, 122

sexual interest arousal disorder (SIAD),  25–26

Sodomy, criminalization of,  312

Spinal cord injury,  142–143,  463–464\.  See also Medical problems Static-99,  229

Stepped care, 448–449

Steroid hormones, 22

Stimuli,  21–22

Stimulus control,  52–53,  469,  548

Stop–start technique, 127, 129

Stressors, 48,  74–75,  315–316

Structured interview. See also Assessment

adolescents and young adults,  518

culturally sensitive sex therapy (CSST) and,  345–346

delayed ejaculation and, 144–145

erectile dysfunction and, 76

genital pain, 162

525

hypoactive sexual desire disorder (HSDD) in men and, 49–50

infertility and,  422–423

premature ejaculation and, 122,  123

sexual interest arousal disorder (SIAD),  26, 28

vaginismus and, 181–182

Subjective excitement scale, 127,  129

Substance abuse disorders, 287–288

Substance dependence, 47,  72–73

Suicide risk, 254

SWAN survey,  338

Symptoms/criteria, 19–20,  265–266\.  See also Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Syphilis, 496\.  See also Sexually transmitted infections (STIs) Systematic desensitization, 99

**T**

Testosterone. See also Testosterone therapy

aging and, 527

hypoactive sexual desire disorder (HSDD) in men,  47

infertility and,  421

sexual interest arousal disorder (SIAD),  23

Testosterone therapy. See also Hormonal treatment; Testosterone

hypoactive sexual desire disorder (HSDD) in men,  47

orgasm disorders in women and,  101

overview, 51

sexual interest arousal disorder (SIAD),  33–34

Theoretical models,  21–26,  383–385

Therapeutic relationship,  121, 205–206,  407

Therapist-aided exposure treatment, 185–186,  187–190\.  See also Exposure therapy Third-wave CBTs (TWCBTs),  469–472\.  See also Cognitive-behavioral therapy (CBT) Three windows approach,  95–96

Thyroid functioning, 29,  51, 118,  421

Transgender clients,  7, 316–317,  318–319\.  See also Gender dysphoria; Gender-variant youth; LGBTQ clients Transsexual individuals, 250–252, 252,  253–255. See also Gender dysphoria Transvestic disorder diagnoses, 317

Transvestic fetishism,  197. See also Paraphilias

TransYouth-FamilyAllies (TYFA), 327

Trauma, 181–182, 387–388\.  See also Sexual abuse Trauma-focused models, 384

Traumatic brain injury,  464

Traumatic sexualization model,  383

Treatment. See also Interventions; individual treatment approaches

access to and cost of,  553

adolescents and young adults,  518–519

aging and, 535–536

body image and,  367–370

chronic illness and,  446–450

contribution of sex therapy,  549

delayed ejaculation and, 145–147

erectile dysfunction and, 69–71,  71–81

expectations from, 552–553

gender dysphoria and, 244–258

genital pain, 159,  165–169

hypersexual disorders (HDs), 289–299,  290t

hypoactive sexual desire disorder (HSDD) in men,  46–49, 50–54,  54f

infertility and,  421,  426–429,  432–433

infidelity and,  405–408

526

male sexual desire and,  45

orgasm disorders in women and,  99–102, 103f

outcomes of,  546–548,  552–553

overview, 545–546

paraphilias and,  202–207,  213–214

pedophilia and,  226–227

people with disabilities and,  466–474

persistent genital arousal disorder (PGAD) and,  270–273

premature ejaculation,  113, 124f,  125–134

queer theory paradigm and,  314

sexual abuse and,  385–389

sexual interest arousal disorder (SIAD) and,  2–3, 27f,  29–35

vaginismus and, 184–187,  190–191

Treatment motivation, 182

Trichomonas vaginalis,  499. See also Sexually transmitted infections (STIs) Tricyclic antidepressants, 273\.  See also Antidepressants; Pharmacological treatment Triphasic sexual response, 542–544

Trust, 290t, 403

12-step programs,  287f, 290t,  293–295

**U**

UPOINT classification system, 165

Urological chronic pelvic pain syndrome (UCPPS) in men, 3–4, 165\.  See also Genital pain Uterine fibroids,  421

Utrecht Gender Dysphoria Scale, 241

**V**

Vaginal Penetration Cognition Questionnaire (VPCQ), 182

Vaginal penetration phobia, 177–178, 185–186\.  See also Vaginismus Vaginismus. See also Genital pain

assessment and diagnostic issues,  181–184

case example of, 187–190

deletion of in the DSM-5,  3

etiology, 179–181,  180f

overview, 177–178,  190–191

prevalence, 179

treatment and,  184–187

Validation of sexuality, 446–448

Values,  470–472

Values clarification exercise, 470–472

Vasovagal syncope,  183–184

Vestibulectomy, 166–167. See also Treatment Viral STIs, 496–499\.  See also Herpes; HIV; Sexually transmitted infections (STIs) Voyeurism. See also Paraphilias

case example of, 207–214

infidelity and,  406–407

overview, 197,  214

Vulvodynia,  160–161,  166\.  See also Genital pain Vulvovaginal candidiasis, 499–500. See also Sexually transmitted infections (STIs) **W**

Women's International Study of Health and Sexuality (WISHeS),  20

World Professional Association for Transgender Health (WPATH), 313,  317

527

**Y**

Yeast infection, 499–500\.  See also Sexually transmitted infections (STIs) Young adults. See also Adolescents; Adults

assessment and diagnostic issues,  515–517

case example of, 519–522

epidemiology, 513–515

etiology, 517

overview, 511–513,  522–523

treatment and,  518–519

Youth Self-Report Form (YSR), 237

528

About Guilford Press

www.guilford.com

Founded in 1973, Guilford Publications, Inc., has built an international reputation as a publisher of books, periodicals, software, and DVDs in mental health, education, geography, and the social and behavioral sciences. We pride ourselves on teaming up with authors who are recognized experts, and who translate their knowledge into vital, needed resources for practitioners, academics, and general readers. Our dedicated editorial professionals work closely on each title to produce high-quality content that readers can rely on. The firm is owned by its founding partners, President Bob Matloff and Editor-in-Chief Seymour Weingarten, and many staff members have been at Guilford for more than 20 years.

529

Discover Related Guilford Books

Sign up to receive e-Alerts with new book news and special offers in your fields of interest:

http://www.guilford.com/ealerts.

Experience

Guilford Periodicals Online

Taking periodicals to the next level, our website offers exciting features and new ways to access up-to-the-minute information and perspectives. Visit www.guilfordjournals.com to view sample issues, order individual articles or thematic collections, or purchase a 24-hour Day Pass to download any articles on our site. You can also search for authors or keywords across one—or all—Guilford periodicals, subscribe to table of contents alerts or RSS feeds, see our Most Viewed and Most Cited Articles, and use a variety of social media options to share free content with your friends.

530


Input: Write an outline for a comprehensive document on sex therapy, including sections on sexual dysfunction, other sexual disorders, and the therapeutic challenges for sex therapy. The document should include detailed chapters on various disorders such as sexual interest/arousal disorder in women, low sexual desire in men, erectile dysfunction, orgasm disorders, genital pain, and vaginismus. Also, include chapters on paraphilias, pedophilia, gender dysphoria, persistent genital arousal disorder, and hypersexuality disorders. Furthermore, discuss the specific challenges in treating LGBTQ clients, culturally sensitive sex therapy, body image and sexuality, sexual abuse survivors, infidelity, infertility, chronic illness, disability, sexually transmitted infections, and sexual problems in adolescents and young adults. Include a conclusion on the current state and future of sex therapy.

Response:
# Document Outline

  * Title Page
  * Copyright Page
  * Dedication Page
  * About the Editors
  * Contributors
  * Preface
  * Contents
  * Introduction. The Future of Sex Therapy
  * PART I - SEX THERAPY FOR SEXUAL DYSFUNCTION
    * Desire and Arousal
      * 1\. Sexual Interest/Arousal Disorder in Women
      * 2\. Hidden Disorder/Hidden Desire: Presentations of Low Sexual Desire in Men
      * 3\. Erectile Dysfunction: Integration of Medical and Psychological Approaches
    * Orgasm
      * 4\. Orgasm Disorders in Women
      * 5\. Treatment of Premature Ejaculation: Psychotherapy, Pharmacotherapy, and Combined Therapy
      * 6\. Delayed Ejaculation
    * Pain
      * 7\. Genital Pain in Women and Men: It Can Hurt More Than Your Sex Life
      * 8\. Lifelong Vaginismus
  * PART II - SEX THERAPY FOR OTHER SEXUAL DISORDERS
    * 9\. The Paraphilias: An Experiential Approach to "Dangerous" Desires
    * 10\. "Gold-Star Pedophiles" in General Sex Therapy Practice
    * 11\. Gender Dysphoria
    * 12\. Persistent Genital Arousal Disorder
    * 13\. Nonparaphilic Hypersexuality Disorders
  * PART III - THERAPEUTIC CHALLENGES FOR SEX THERAPY
    * Specific Groups
      * 14\. Therapy with LGBTQ Clients: Working with Sex and Gender Variance from a Queer Theory Model
      * 15\. Culturally Sensitive Sex Therapy: The Need for Shared Meanings in the Treatment of Sexual Problems
      * 16\. Body Image and Sexuality
      * 17\. The Treatment of Sexual Dysfunctions in Survivors of Sexual Abuse
      * 18\. Infidelity
    * Medical Problems
      * 19\. Sexuality and Infertility
      * 20\. Sexuality in the Context of Chronic Illness
      * 21\. Sexuality and Disability: A Disability-Affirmative Approach to Sex Therapy
      * 22\. Suppose They Gave an Epidemic and Sex Therapy Didn't Attend?: Sexually Transmitted Infection Concerns in the Sex Therapy Context
    * Lifespan Changes
      * 23\. Sexual Problems in Adolescents and Young Adults
      * 24\. Sexuality and Aging
      * Conclusion. Sex Therapy in Transition: Are We There Yet?
  * Index
  * About Guilford Press
  * Discover Related Guilford Books